MedTrace Logo

VAC Bioburden Wound Care Assessment

NCT04826965 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-11-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the microbiologic burden and need for further operative debridement of patients undergoing primary surgical debridement of infected tissue, soft tissue abscesses, or traumatic wounds of the upper and lower extremity.

Conditions

  • Upper Extremity Wound
  • Lower Extremity Wound
  • Soft Tissue Abscesses
  • Traumatic Wounds

Interventions

DEVICE

Wound Vac is applied

A wound vac or wound vac with cleanse choice dressing, track pad duo, and saline irrigation is applied.

Sponsors & Collaborators

Principal Investigators

  • Suhail Mithani, MD · Duke Health System

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-10-13
Completion
2022-10-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04826965 on ClinicalTrials.gov